ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer

Wang, Yupeng; Luo, Zhijian; Zhou, Dongfang; Wang, Xuefeng; Chen, Jianjun; Gong, Shipeng; Yu, Zhiqiang*南方医科大学; 1
Biomaterials Science2021-6-7DOI: 10.1039/d1bm00087j
19被引9阅读
引用收藏
分享

摘要

As the most common cause of gynecological cancer-related deaths worldwide, ovarian cancer requires novel therapy strategies. Pt(ii)-Based antitumor drugs (e.g. cisplatin) are one of the most successful and frequently used drugs in ovarian cancer chemotherapy at present. However, drug resistance and severe side effects are the major problems in cancer treatment. Herein, the design of a reduction responsive platinum(iv) (Pt(iv))/ursolic acid (UA)/polyethylene glycol (PEG) dual prodrug amphiphile (Pt(iv)-UA-PEG) to treat cisplatin-resistant ovarian cancer is reported for the first time. Pt(iv)-UA-PEG could self-assemble into nanoparticles (Pt(iv)-UA NPs) with a fixed and precise Pt/UA ratio, and a constantly high content of drugs. Pt(iv)-UA NPs could be efficiently taken up by cisplatin-resistant ovarian cancer cells and release the drug in intracellular reductive and acidic environments. In vitro studies show that the released UA and cisplatin have different anticancer mechanisms, and their synergistic effects overcome the detoxification and anti-apoptotic mechanisms of cancer cells. Furthermore, the in vivo results indicate that Pt(iv)-UA NPs have a prolonged blood circulation time, enhanced tumor accumulation, and significantly improved antitumor efficacy in A2780/DDP tumor-bearing mice, without causing any side effects. In summary, our results demonstrate that the development of the stimuli-responsive dual prodrug amphiphile nano-assembly provides a new strategy to overcome drug resistance.

相关
加载中…
  • Alantolactone-Loaded Pegylated Prodrug Nanocarriers for Synergistic Treatment of Cisplatin-Resistant Ovarian Cancer via Reactivating Mitochondrial Apoptotic Pathway
    Luo, Zhijian; Luo, Yantao; Liang, Xiaoling; Lyu, Qingyang; Meng, Fanliang; Chen, Xuncai; Wang, Yupeng; Fang, Weiyi*; Li, Aimin*; Zhou, Dongfang*ACS Biomaterials Science & Engineering, 2022, 8(6): 2526-2536.
  • Self-assembly nanoplatform of platinum (IV) prodrug for enhanced ovarian cancer therapy
    Ma, Xiao; Liu, Yangjia; Wu, Hanmei; Tan, Jinxiu; Yi, Wenying; Wang, Zhenjie*; Yu, Zhiqiang*; Wang, Xuefeng*Materials Today Bio, 2023, 21: 100698.被引 1
  • Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies
    Wang, Lina; Liu, Zejun; He, Shumei; He, Shasha; Wang, Yupeng*Journal of Materials Chemistry B, 2021, 9(22): 4587-4595.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomaterials Science
发表日期
2021-06-07
卷期
第 9 卷, 第 11 期
页码
4110-4119
DOI
10.1039/d1bm00087j
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [51903119, 51773198, 81402127, 81773642]; China Postdoctoral Science Foundation [2020M672543]; Nanfang Hospital President Research Fund [2019B019]

作者

  • W

    Wang, Yupeng (第一作者)

    1 · southern med univ

  • L

    Luo, Zhijian

    southern med univ

查看全部 7 位作者收起作者
  • Z

    Zhou, Dongfang

    southern med univ

  • W

    Wang, Xuefeng

    southern med univ

  • C

    Chen, Jianjun

    southern med univ · 1

  • G

    Gong, Shipeng

    southern med univ · 1

  • Y

    Yu, Zhiqiang (通讯)

    southern med univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417